SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Challenges and opportunities of drug repositioning
2 references·2 citing·17 second hop
Challenges and opportunities of drug repositioning (2013)Challenges and opportunities of drug repo…Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs (2010)Trends in Risks Associated Wi…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…Drug repurposing: a systematic review on root causes, barriers and facilitators (2022)Drug repurposing: a systemati…On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients (2020)On-Label or Off-Label? Overco…The price of innovation: new estimates of drug development costs (2003)Can the pharmaceutical industry reduce attrition rates? (2004)Deconstructing the Drug Development Process: The New Face of Innovation (2010)Killer Acquisitions (2020)How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment (2021)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Drug repurposing in oncology—patient and health systems opportunities (2015)Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics (2017)Overcoming the legal and regulatory barriers to drug repurposing (2018)Recovering Abandoned Compounds through Expanded External IP Licensing (2013)How to conduct a bibliometric analysis: An overview and guidelines (2021)Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic (2023)Data-Driven Enterprise Architecture for Pharmaceutical R&D (2024)
this work references cited by second hop

References

  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,562 cited
  • 2010Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs847 cited

Cited by

  • 2022Drug repurposing: a systematic review on root causes, barriers and facilitators280 cited
  • 2020On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients79 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work